Italian study tracks how long CLL patients stay on acalabrutinib in everyday care
NCT ID NCT06205498
First seen Jan 26, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This study looks at how long people with chronic lymphocytic leukemia (CLL) stay on the drug acalabrutinib when it's used in regular medical practice in Italy. Researchers will track 151 patients who started the drug between 2021 and 2022, noting why some stop treatment. The goal is to understand real-world use beyond clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alessandria, 15121, Italy
-
Research Site
Ancona, 60126, Italy
-
Research Site
Bari, 70124, Italy
-
Research Site
Barletta, 76121, Italy
-
Research Site
Brindisi, 72100, Italy
-
Research Site
Campobasso, 86100, Italy
-
Research Site
Catania, 95100, Italy
-
Research Site
Catanzaro, 88100, Italy
-
Research Site
Cosenza, 87100, Italy
-
Research Site
Crema, 26013, Italy
-
Research Site
Cuneo, 12100, Italy
-
Research Site
Foggia, 71122, Italy
-
Research Site
Frosinone, 03100, Italy
-
Research Site
Genova, 16132, Italy
-
Research Site
Lecce, 73100, Italy
-
Research Site
Messina, 98158, Italy
-
Research Site
Milan, 20122, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Monza, 20900, Italy
-
Research Site
Naples, 80131, Italy
-
Research Site
Padova, 35128, Italy
-
Research Site
Pagani, 84016, Italy
-
Research Site
Perugia, 06132, Italy
-
Research Site
Pescara, 65124, Italy
-
Research Site
Ravenna, 48121, Italy
-
Research Site
Reggio Calabria, 89133, Italy
-
Research Site
Roma, 00133, Italy
-
Research Site
Roma, 00161, Italy
-
Research Site
Roma, 00168, Italy
-
Research Site
Roma, 00184, Italy
-
Research Site
Roma, 00189, Italy
-
Research Site
Rozzano, 20089, Italy
-
Research Site
Salerno, 84078, Italy
-
Research Site
San Giovanni Rotondo, 71013, Italy
-
Research Site
Torino, 10043, Italy
-
Research Site
Torino, 10073, Italy
-
Research Site
Torino, 10126, Italy
-
Research Site
Torino, 10154, Italy
-
Research Site
Tricase, 73039, Italy
-
Research Site
Varese, 21100, Italy
-
Research Site
Viterbo, 01100, Italy
Conditions
Explore the condition pages connected to this study.